169 related articles for article (PubMed ID: 7989744)
41. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway.
Parra-López CA; Lindner R; Vidavsky I; Gross M; Unanue ER
J Immunol; 1997 Mar; 158(6):2670-9. PubMed ID: 9058800
[TBL] [Abstract][Full Text] [Related]
42. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation.
Bertolino P; Staschewski M; Trescol-Biémont MC; Freisewinkel IM; Schenck K; Chrétien I; Forquet F; Gerlier D; Rabourdin-Combe C; Koch N
J Immunol; 1995 Jun; 154(11):5620-9. PubMed ID: 7751615
[TBL] [Abstract][Full Text] [Related]
43. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
Karlsson L
Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
[TBL] [Abstract][Full Text] [Related]
44. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
45. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
[TBL] [Abstract][Full Text] [Related]
46. Invariant chain-independent antigen presentation depends primarily upon the pool of newly synthesized MHC class II molecules.
Swier K; Miller J
J Immunol; 1995 Aug; 155(4):1851-61. PubMed ID: 7636238
[TBL] [Abstract][Full Text] [Related]
47. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.
Stebbins CC; Loss GE; Elias CG; Chervonsky A; Sant AJ
J Exp Med; 1995 Jan; 181(1):223-34. PubMed ID: 7807005
[TBL] [Abstract][Full Text] [Related]
48. Nonclassical MHC class II molecules.
Alfonso C; Karlsson L
Annu Rev Immunol; 2000; 18():113-42. PubMed ID: 10837054
[TBL] [Abstract][Full Text] [Related]
49. The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed.
Wolf PR; Tourne S; Miyazaki T; Benoist C; Mathis D; Ploegh HL
Eur J Immunol; 1998 Sep; 28(9):2605-18. PubMed ID: 9754549
[TBL] [Abstract][Full Text] [Related]
50. Functional analysis of the antigen binding region of an MHC class II molecule.
Rosloniec EF; Beard KS; Freed JH
Mol Immunol; 1993 Apr; 30(5):491-501. PubMed ID: 7681933
[TBL] [Abstract][Full Text] [Related]
51. Cutting edge: H-2DM is responsible for the large differences in presentation among peptides selected by I-Ak during antigen processing.
Lovitch SB; Petzold SJ; Unanue ER
J Immunol; 2003 Sep; 171(5):2183-6. PubMed ID: 12928360
[TBL] [Abstract][Full Text] [Related]
52. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells.
Denzin LK; Robbins NF; Carboy-Newcomb C; Cresswell P
Immunity; 1994 Oct; 1(7):595-606. PubMed ID: 7600288
[TBL] [Abstract][Full Text] [Related]
53. Novel mutants define genes required for the expression of human histocompatibility leukocyte antigen DM: evidence for loci on human chromosome 6p.
Fling SP; Rak J; Muczynski KA; Arp B; Pious D
J Exp Med; 1997 Nov; 186(9):1469-80. PubMed ID: 9348304
[TBL] [Abstract][Full Text] [Related]
54. Class II antigen processing compartments and the function of HLA-DM.
Green JM; Pierce SK
Int Rev Immunol; 1996; 13(3):209-19. PubMed ID: 8782742
[TBL] [Abstract][Full Text] [Related]
55. Intracellular interference with antigen presentation.
Leyva-Cobian F; Unanue ER
J Immunol; 1988 Sep; 141(5):1445-50. PubMed ID: 3137257
[TBL] [Abstract][Full Text] [Related]
56. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.
Vogt AB; Kropshofer H; Hämmerling GJ
Hum Immunol; 1997 May; 54(2):170-9. PubMed ID: 9297535
[TBL] [Abstract][Full Text] [Related]
57. Altered antigen presentation in mice lacking H2-O.
Liljedahl M; Winqvist O; Surh CD; Wong P; Ngo K; Teyton L; Peterson PA; Brunmark A; Rudensky AY; Fung-Leung WP; Karlsson L
Immunity; 1998 Feb; 8(2):233-43. PubMed ID: 9492004
[TBL] [Abstract][Full Text] [Related]
58. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments.
Sanderson F; Kleijmeer MJ; Kelly A; Verwoerd D; Tulp A; Neefjes JJ; Geuze HJ; Trowsdale J
Science; 1994 Dec; 266(5190):1566-9. PubMed ID: 7985027
[TBL] [Abstract][Full Text] [Related]
59. Cutting edge: editing of recycling class II:peptide complexes by HLA-DM.
Pathak SS; Lich JD; Blum JS
J Immunol; 2001 Jul; 167(2):632-5. PubMed ID: 11441064
[TBL] [Abstract][Full Text] [Related]
60. Truncation of the A alpha chain of MHC class II molecules results in inefficient antigen presentation to antigen-specific T cells.
Wade WF; Ward ED; Rosloniec EF; Barisas BG; Freed JH
Int Immunol; 1994 Oct; 6(10):1457-65. PubMed ID: 7826938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
